ArticleOxford medical case reports2026
Detection of occult non-mass enhancement in bloody nipple discharge using US/MRI fusion imaging: a case report.
Article in Oxford medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 66-year-old woman presented with right bloody nipple discharge (BND). Initial evaluation, including palpation, mammography (MMG), ultrasonography (US), and cytology, revealed no abnormalities. In the second year, persistent BND prompted breast magnetic resonance imaging (MRI), which demonstrated non-mass enhancement in the lower right breast and was classified as Breast Imaging Reporting and Data System (BI-RADS) category 3; therefore, imaging surveillance was performed. In the third year, cytological examination revealed atypical cells. Repeat MRI again demonstrated non-mass enhancement. US/MRI fusion identified two suspicious regions; however, ultrasound-guided needle biopsy showed no evidence of malignancy. Because of persistent BND and cytological atypia, excisional biopsy was performed, and ductal carcinoma in situ (DCIS) was confirmed. US/MRI fusion may assist in localizing target areas for biopsy in patients with MRI-detected lesions without corresponding findings on MMG or US; however, histopathological confirmation remains essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.